v3 Template
R

Regenerative Medical Solutions

Biotechnology ~360 employees
Founded
--
Employees (Est.)
~360
18 leaders known
Total Funding
$3.6M
Funding Rounds
2
Last Funding
2025-10-01

About Regenerative Medical Solutions

Regenerative Medical Solutions (RMS) is a biotech company focused on developing a functional cure for diabetes using stem cell therapy. Their mission is to eliminate insulin dependency in diabetic patients by leveraging regenerative medicine to restore pancreatic function, aiming to bring an affordable and scalable solution to market.

Products & Services

Stem Cell Therapy for Diabetes:A prospective cure that transforms stem cells into insulin-producing cells, designed to be scalable and affordable for type 1 and type 2 diabetes patients.
ILC Cell Generation Kit:A product to help biotech companies cultivate pancreatic cells more efficiently.
ProgenMix™ Media Formulation:A formulation designed to support pancreatic cell cultivation for other biotech companies.
Life Science Consulting Services:Customizable consulting services in stem cell and diabetes research for pharmaceutical and biotech companies.

Specialties

Stem Cell Therapy Diabetes Treatment Regenerative Medicine Induced Pluripotent Stem Cells (iPSCs) Pancreatic Beta Islet Cell Production

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: SBIR Grant
T: -
FT: SBIR Grant 		A: 1800000
MR: -
FA: approximately $1.8 million
FAN: 1800000 		D: 2025-10-01
FD: 2025-10-01 		1 investors
2 RT: Phase II SBIR Grant
T: -
FT: Phase II SBIR Grant 		A: 1800000
MR: -
FA: approximately $1.8 million
FAN: 1800000 		D: 2025-10-01
FD: 2025-10-01 		1 investors
SBIR Grant Latest
2025-10-01
$1.8M
1 investor (Pro only)
Phase II SBIR Grant 2025-10-01
$1.8M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

H

Harry M. Jansen Kraemer Jr.

Advisor

P

Peter G. Stock

Advisor

W

W. Ed Tyler

Advisor

S

Su-Chun Zhang

Advisor

A

Alan Lewis

Advisor

T

Tommy G. Thompson

Advisor

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Regenerative Medical Solutions Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~360 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro